Holen Sie sich die Stockscreener-App
7.85
10.41%
0.74
Aspire Biopharma Holdings Inc Aktie (ASBP) Neueste Nachrichten
S&R Associates Advises MiddleGround Capital on Sale of Dura Driver Control Systems to Aspire Biopharma Holdings - SCC Online
Aspire Biopharma (NASDAQ: ASBP) slashes H1 2026 loss and rebuilds equity - Stock Titan
Aspire Biopharma Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th - ACCESS Newswire
S&R Associates represented MiddleGround Capital - Lexology
ASBP Stock Back On Retail Radar After 78% Crash – Bulls Eye $1 Comeback - Stocktwits
LCID, ASBP, WLDS Stocks Hit 52-Week Lows: What Drove The Selloff? - Stocktwits
ASBP Stock Heads For Best Week In Over 2 Months – Why This Drug Delivery Tech Firm Is Buying An Auto Supplier? - Stocktwits
Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin - Watertown Public Opinion
EXCLUSIVE: Aspire Biopharma Buys Its Way Into Global Auto Market With $30 Million DCS Deal - Yahoo Finance
Form 8K Aspire Biopharma Holdings Inc For: 10 August By Investing.com - Investing.com Nigeria
Aspire Biopharma Completes $30 Million Acquisition of Dura Driver Control Systems - citybiz
Aspire Biopharma Closes Acquisition of FireFish Units Under Asset and Equity Purchase Agreement - TradingView
Aspire Biopharma completes $30M automotive supplier acquisition - Investing.com
Aspire Biopharma Completes Acquisition of Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue - ACCESS Newswire
Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack - The Northwest Florida Daily News
Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance With Continued Listing Requirements - 富途牛牛
Aspire Biopharma Holdings Inc (ASBP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aspire Biopharma Holdings Inc (ASBP) Valuation: PE, PB & Fair Value Analysis - TradingKey
Aspire Biopharma Holdings Inc (ASBP) Cash Flow - TradingKey
Aspire Biopharma Holdings Inc (ASBP) Income Statement - TradingKey
Aspire Biopharma Holdings Inc (ASBP) Institutional Confidence - TradingKey
Aspire Biopharma Holdings Inc (ASBP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Aspire Biopharma Holdings, Inc. Revenue Breakdown – NASDAQ:ASBPW - TradingView
TradingKey - TradingKey
ASBP|Aspire Biopharma Holdings Inc|Price:7.150|Chg%:-0.110 - TradingKey
Aspire Biopharma Holdings Inc (ASBP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Aspire Biopharma Holdings Inc (ASBP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Aspire Biopharma Holdings Inc (ASBP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Aspire Biopharma Holdings, Inc. Revenue Breakdown – NASDAQ:ASBP - TradingView
ASBP|Aspire Biopharma Holdings Inc|Price:7.260|Chg%:+0.050 - TradingKey
Enterprise value to revenue forward of Aspire Biopharma Holdings, Inc. – NASDAQ:ASBP - TradingView
Aspire Biopharma (ASBP) Financials 2026Income Statement and Balance Sheet - MarketBeat
Aspire Biopharma Holdings, Inc. (NASDAQ: ASBP) Files 8-K for July 2026 – Company Details, Stock & Warrants Information – Minichart - Minichart
Aspire Bi clarifies public warrant terms after two reverse stock splits; exercise price now $13,800 - TradingView
Aspire Biopharma Warrants Stay Flat at $0.02 as Trading Remains Range-BoundRunaway Gap - dars.gov.et
$Aspire Biopharma (ASBP.US)$ - Moomoo
Freestyle Motocross Legend Jarryd McNeil Named Newest Sponsored Athlete for Aspire Biopharma's BUZZ BOMB(TM) - ACCESS Newswire
Aspire Biopharma Holdings, Inc.: Freestyle Motocross Legend Jarryd McNeil Named Newest Sponsored Athlete for Aspire Biopharma's BUZZ BOMB - FinanzNachrichten.de
ASBP Stock Jumps 21% On Buyback Offer – Retail Believes Every Dip’s A Buying Opportunity - Stocktwits
Aspire Biopharma (ASBP) Edges Higher at $6.04; Support and Resistance Levels in FocusDealer Positioning - dars.gov.et
Aspire Biopharma Holdings Inc (ASBP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, to Showcase BUZZ BOMB(TM) Caffeine and its Innovative Sublingual Delivery Technology at The Sports & Active Nutrition Summit - Independent Mail
OTC Markets Life Sciences Investor Forum: Stephen Quesenberry, General Counsel and Director of Product Development, of Aspire Biopharma with Zacks SCR’s David Bautz, PhD - Yahoo Finance
Price to earnings forward of Aspire Biopharma Holdings, Inc. – BOATS:ASBPW - TradingView
Enterprise value to revenue forward of Aspire Biopharma Holdings, Inc. – BOATS:ASBPW - TradingView
Price to book forward of Aspire Biopharma Holdings, Inc. – NASDAQ:ASBPW - TradingView
Number of shareholders of Aspire Biopharma Holdings, Inc. – NASDAQ:ASBPW - TradingView
Price to sales forward of Aspire Biopharma Holdings, Inc. – NASDAQ:ASBPW - TradingView
Enterprise value to EBIT forward of Aspire Biopharma Holdings, Inc. – NASDAQ:ASBPW - TradingView
Enterprise value to revenue forward of Aspire Biopharma Holdings, Inc. – NASDAQ:ASBPW - TradingView
Aspire Biopharma to implement 1-for-30 reverse stock split - Investing.com
Price to book forward of Aspire Biopharma Holdings, Inc. – NASDAQ:ASBP - TradingView
0.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):